Duchenne Muscular Dystrophy: Connecting the Dots Between Pathophysiology and Treatment
On Wednesday, June 10, 2026, join ITF Therapeutics for a webinar on the complexities of managing Duchenne muscular dystrophy (DMD). Presented by Dr. Daniel Guillen Mendoza, the session will explore the underlying biology and progression of DMD, highlight unmet treatment needs, and discuss evolving therapeutic approaches to improve patient care.
Note: This partner-sponsored webinar is made possible by the support of ITF Therapeutics, a valued CNS annual partner. Their sponsorship enables us to bring you cutting-edge insights and discussions from industry experts.
Speaker
Daniel Guillen Mendoza, MD